WH
www.hicelltech.com
HiCellTech develops stem cell-based therapies and drug efficacy evaluation platforms specifically targeting cancer stem cells and mesenchymal stem cell treatments. The company addresses the need for effective therapies against metastatic cancer and evaluates drug toxicity, enabling the development of targeted anti-cancer treatments.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- HiCellTech develops stem cell-based therapies and drug efficacy evaluation platforms specifically targeting cancer stem cells and mesenchymal stem cell treatments. The company addresses the need for effective therapies against metastatic cancer and evaluates drug toxicity, enabling the development of targeted anti-cancer treatments.